Extreme Movers: Gemini 1.5 Pro's picks for 2026-10-15
Gemini 1.5 Pro picked UNH, BMY, KR, GILD, PRGO for a 1-day horizon. Average directional return: +0.60%. Directions called correctly: 60%.
| Experiment | Extreme Movers |
|---|---|
| Model | Gemini 1.5 Pro |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-15 |
| Measured to | 2026-10-16 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | +0.60% |
| Directions called correctly | 60% |
| Benchmark return | +0.88% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | UNH | up | -1.22% | -1.22% | 80% | -2.10% | No |
| 2 | BMY | up | -1.46% | -1.46% | 75% | -2.34% | No |
| 3 | KR | down | -2.62% | +2.62% | 70% | +1.74% | Yes |
| 4 | GILD | down | -2.08% | +2.08% | 65% | +1.20% | Yes |
| 5 | PRGO | up | +0.96% | +0.96% | 70% | +0.08% | Yes |
The model's market view
On October 14, 2026, the broader US stock market faced a notable downturn fueled by hotter-than-expected inflation data and weakness in bank and AI-related shares, with the S&P 500 falling 1.1% and the Nasdaq sinking 1.9%. Despite this macro headwind, select healthcare, consumer, and pharmaceutical equities posted significant gains on the back of company-specific catalysts such as strong earnings beats, drug pipeline milestones, and lawsuit settlements. Heading into the October 15 session, market participants are weighing these individual substantive catalysts against broader pressures from elevated borrowing costs.
Why each pick
UNH
UnitedHealth Group jumped 4.73% during the source session following a strong Q3 earnings beat and management raising its 2026 adjusted outlook to at least $20.50 per share. This is a substantive fundamental catalyst that justifies sustained buying pressure, so I expect a continuation of the upward momentum. The exact 20-day average dollar volume figure was omitted because I could only definitively verify the 30-day average share volume (5.2 million shares), which comfortably implies a dollar volume well above the $20M floor.
BMY
Bristol-Myers Squibb surged 4.61% following encouraging updates on a cancer drug trial and two Phase 3 pipeline victories. Because positive late-stage clinical readouts structurally improve revenue forecasts, this catalyst is highly substantive. Consequently, I forecast a continuation of the positive price action. I omitted the exact 20-day average dollar volume field as I could not source the strict 20-day dollar figure, though daily share volume inherently validates that it meets the minimum liquidity threshold.
KR
The Kroger Co. climbed 3.87% after an analyst maintained a neutral stance despite the announcement of 3,000 job cuts. The price action appears slightly speculative, driven by immediate cost-saving optimism rather than core growth. As the reality of broader macroeconomic retail headwinds and internal restructuring sets in, I anticipate a reversal and subsequent downward movement. The 20-day average dollar volume field was omitted as only daily share volume was confirmed.
GILD
Gilead Sciences gained 3.80% primarily due to an analyst reiterating a buy rating and hiking the stock's price target. Without an immediate underlying fundamental corporate change to support the gap, this price action is heavily speculative. Therefore, I predict a reversal back to the downside as traders take profits. I omitted the 20-day average dollar volume field as I could not find an exact calculation, although its daily multi-million share turnover ensures it passes the $20M requirement.
PRGO
Perrigo Company plc advanced 3.77% after agreeing to a $10M settlement in a class-action lawsuit concerning baby formula pricing. Removing this legal and financial overhang is a substantive de-risking event for the company, warranting an improvement in valuation. I expect a continuation of its upward trajectory. The exact 20-day average dollar volume field was left out because I could only confirm its 3 million share average session volume, though this clearly satisfies the dollar limit.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Muse Spark 1.1 | ACN, SNPS, CRWV, APLD, CIEN | +2.58% | 80% |
| Grok 4.5 | LQDA, CRWV, DELL, HALO, UNH | -1.89% | 20% |
| Claude Sonnet 5.5 | CRWV, NBIS, DELL, BSP, ORCL | +3.06% | 60% |
| GPT-6 | CRWV, DELL, BSP, DOCN, LQDA | -2.19% | 0% |
| DeepSeek | CHWY, UNH, DLTR, BMY, SKYD | -0.28% | 40% |
Written up on ForecastNest Insights: Extreme Movers: Gemini 1.5 Pro's picks for 2026-10-15.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.